Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,610
Total Claims
$1.6M
Drug Cost
1,200
Beneficiaries
$1,343
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-98%
Opioid rate vs peers
0.0% vs 2.2% avg
-5%
Cost per patient vs peers
$1,343 vs $1,411 avg
+27%
Brand preference vs peers
13.5% vs 10.6% avg
Brand vs Generic
Brand: 3,404 claims · $1.2M
Generic: 21,889 claims · $378K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 261 | $180K |
| Apixaban | 182 | $110K |
| Insulin Glargine,hum.Rec.Anlog | 219 | $90K |
| Dapagliflozin Propanediol | 107 | $78K |
| Linagliptin | 110 | $67K |
| Empaglifloz/Linaglip/Metformin | 112 | $67K |
| Linagliptin/Metformin Hcl | 94 | $58K |
| Empagliflozin/Metformin Hcl | 84 | $49K |
| Sitagliptin Phos/Metformin Hcl | 80 | $45K |
| Insulin Lispro | 90 | $41K |
| Rivaroxaban | 50 | $34K |
| Insulin Glargine-Yfgn | 186 | $31K |
| Levothyroxine Sodium | 467 | $30K |
| Sitagliptin Phosphate | 33 | $25K |
| Atorvastatin Calcium | 1,632 | $22K |
Prescribing Profile
Patient Profile
72
Avg Age
60%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data